Provided by Tiger Fintech (Singapore) Pte. Ltd.

Viking Therapeutics

32.01
-0.0600-0.19%
Post-market: 32.200.1900+0.59%19:59 EDT
Volume:3.39M
Turnover:109.42M
Market Cap:3.60B
PE:-27.76
High:33.16
Open:32.16
Low:31.28
Close:32.07
Loading ...
Apr 26, 2023

Major Issues Report

8-K - Current report
Apr 26, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 24, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 19, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 17, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 17, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 17, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 17, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 17, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 03, 2023

Major Issues Report

8-K - Current report
Mar 31, 2023

Major Issues Report

8-K - Current report
Mar 30, 2023

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Mar 28, 2023

Major Issues Report

8-K - Current report
Mar 28, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 10, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 09, 2023

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Feb 08, 2023

Major Issues Report

8-K - Current report
Jan 03, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals